Nicolas Burdin

Nicolas Burdin serves as Global Head of Research at Clover. Prior to Clover, Dr. Burdin spent 22 years in positions of increasing responsibility at Sanofi Pasteur where he contributed to the early development and translation of new vaccines against infectious diseases and to the strategic transformation of the company’s R&D technology and pipeline, including the introduction of its mRNA platform.

Dr. Burdin received his Ph.D. in immunology from Lyon 1 University.